Cholera vaccine inactivated oral - International Vaccine Institute
Alternative Names: Cholvax; Euvichol; Euvichol-Plus; ShanCholLatest Information Update: 07 Jul 2023
At a glance
- Originator International Vaccine Institute
- Developer EuBiologics; Incepta Vaccine; International Centre for Diarrhoeal Disease Research; International Vaccine Institute; Sanofi
- Class Cholera vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cholera
Most Recent Events
- 21 Mar 2023 EuBiologics completes a phase-III trial in Cholera (Prevention, In adolescents, In adults, In children) in Nepal (PO) (NCT04760236)
- 06 Oct 2021 Phase-III clinical trials in Cholera (Prevention, In adolescents, In adults, In children) in Nepal (PO) (NCT04760236)
- 28 Nov 2018 No recent reports of development identified for clinical-Phase-Unknown development in Cholera(Prevention) in South Korea (PO, Suspension)